• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短链脂肪酸在炎症性肠病中的作用。

Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.

机构信息

Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.

Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

出版信息

Nutrients. 2023 Oct 21;15(20):4466. doi: 10.3390/nu15204466.

DOI:10.3390/nu15204466
PMID:37892541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10609902/
Abstract

The gut microbiome is a diverse bacterial community in the human gastrointestinal tract that plays important roles in a variety of biological processes. Short-chain fatty acids (SCFA) are produced through fermentation of dietary fiber. Certain microbes in the gut are responsible for producing SCFAs such as acetate, propionate and butyrate. An imbalance in gut microbiome diversity can lead to metabolic disorders and inflammation-related diseases. Changes in SCFA levels and associated microbiota were observed in IBD, suggesting an association between SCFAs and disease. The gut microbiota and SCFAs affect reactive oxygen species (ROS) associated with IBD. Gut microbes and SCFAs are closely related to IBD, and it is important to study them further.

摘要

肠道微生物组是人类胃肠道中多样化的细菌群落,在多种生物过程中发挥重要作用。短链脂肪酸(SCFA)是通过膳食纤维发酵产生的。肠道中的某些微生物负责产生 SCFAs,如乙酸盐、丙酸盐和丁酸盐。肠道微生物组多样性的失衡可导致代谢紊乱和炎症相关疾病。在 IBD 中观察到 SCFA 水平和相关微生物群的变化,提示 SCFAs 与疾病之间存在关联。肠道微生物群和 SCFAs 影响与 IBD 相关的活性氧(ROS)。肠道微生物和 SCFAs 与 IBD 密切相关,进一步研究它们很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/10609902/171463413288/nutrients-15-04466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/10609902/cce819792014/nutrients-15-04466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/10609902/171463413288/nutrients-15-04466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/10609902/cce819792014/nutrients-15-04466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/10609902/171463413288/nutrients-15-04466-g002.jpg

相似文献

1
Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.短链脂肪酸在炎症性肠病中的作用。
Nutrients. 2023 Oct 21;15(20):4466. doi: 10.3390/nu15204466.
2
Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.系统评价和荟萃分析:炎症性肠病患者的短链脂肪酸特征。
Inflamm Bowel Dis. 2019 Oct 18;25(11):1751-1763. doi: 10.1093/ibd/izz188.
3
Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?短链脂肪酸通过肠道屏障、免疫学和微生物群影响炎症性肠病的发展:一种有前途的治疗方法?
J Gastroenterol Hepatol. 2022 Sep;37(9):1710-1718. doi: 10.1111/jgh.15970. Epub 2022 Aug 5.
4
Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.短链脂肪酸补充对结肠炎模型中肠道炎症和微生物组成的影响。
J Nutr Biochem. 2022 Mar;101:108926. doi: 10.1016/j.jnutbio.2021.108926. Epub 2021 Nov 27.
5
The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease.肠道微生物群、短链脂肪酸之间的相互作用及其对宿主健康和疾病的影响。
Gut Microbes. 2024 Jan-Dec;16(1):2393270. doi: 10.1080/19490976.2024.2393270. Epub 2024 Sep 16.
6
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?短链脂肪酸及其产生菌:IBD 的一种被忽视的治疗方法?
EBioMedicine. 2021 Apr;66:103293. doi: 10.1016/j.ebiom.2021.103293. Epub 2021 Apr 1.
7
Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.更高的粪便短链脂肪酸水平与肠道微生物失调、肥胖、高血压和心血管代谢疾病风险因素有关。
Nutrients. 2018 Dec 27;11(1):51. doi: 10.3390/nu11010051.
8
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.短链脂肪酸通过肠道菌群与黏膜免疫系统互作调控肠道稳态及炎症性肠病
Inflamm Bowel Dis. 2018 Feb 15;24(3):558-572. doi: 10.1093/ibd/izx029.
9
Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.肠道微生物衍生短链脂肪酸在癌症中的抗癌作用。
J Microbiol Biotechnol. 2023 Jul 28;33(7):849-856. doi: 10.4014/jmb.2301.01031. Epub 2023 Mar 30.
10
The Therapeutic Role of Short-Chain Fatty Acids Mediated Very Low-Calorie Ketogenic Diet-Gut Microbiota Relationships in Paediatric Inflammatory Bowel Diseases.短链脂肪酸介导极低热量生酮饮食-肠道微生物群在儿科炎症性肠病中的治疗作用。
Nutrients. 2022 Oct 3;14(19):4113. doi: 10.3390/nu14194113.

引用本文的文献

1
Molecular Impact of Magnesium-Mediated Immune Regulation in Diseases.镁介导的免疫调节在疾病中的分子影响
Scientifica (Cairo). 2025 Sep 8;2025:4211238. doi: 10.1155/sci5/4211238. eCollection 2025.
2
Sex differences in the skeletal muscle response to metformin treatment and the possible association with gut-muscle axis in rats.大鼠骨骼肌对二甲双胍治疗反应的性别差异及其与肠-肌轴的可能关联。
Front Endocrinol (Lausanne). 2025 Sep 1;16:1650805. doi: 10.3389/fendo.2025.1650805. eCollection 2025.
3
Promoting cognitive health through the nexus of gut microbiota and dietary phytochemicals.

本文引用的文献

1
Bioactive Components in Fruit Interact with Gut Microbes.水果中的生物活性成分与肠道微生物相互作用。
Biology (Basel). 2023 Oct 13;12(10):1333. doi: 10.3390/biology12101333.
2
Short-chain fatty acids in diseases.短链脂肪酸与疾病
Cell Commun Signal. 2023 Aug 18;21(1):212. doi: 10.1186/s12964-023-01219-9.
3
Investigating the Crime Scene-Molecular Signatures in Inflammatory Bowel Disease.调查犯罪现场-炎症性肠病的分子特征。
通过肠道微生物群与膳食植物化学物质的联系促进认知健康。
Front Nutr. 2025 Aug 29;12:1636131. doi: 10.3389/fnut.2025.1636131. eCollection 2025.
4
Enhanced metagenomic strategies for elucidating the complexities of gut microbiota: a review.用于阐明肠道微生物群复杂性的增强宏基因组学策略:综述
Front Microbiol. 2025 Aug 26;16:1626002. doi: 10.3389/fmicb.2025.1626002. eCollection 2025.
5
Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging Evidence.超加工食品、肠道微生物群与炎症性肠病:对新出现证据的批判性综述
Nutrients. 2025 Aug 19;17(16):2677. doi: 10.3390/nu17162677.
6
Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers.炎症性肠病与心血管疾病之间的病理生理联系:肠道菌群失调及新型生物标志物的作用
Biomedicines. 2025 Jul 31;13(8):1864. doi: 10.3390/biomedicines13081864.
7
Enrichment of short-chain fatty acid-producing bacteria by pH-responsive sodium alginate and chitosan-encapsulated quercetin.通过pH响应性海藻酸钠和壳聚糖包封的槲皮素富集产短链脂肪酸细菌。
Front Microbiol. 2025 Aug 6;16:1594012. doi: 10.3389/fmicb.2025.1594012. eCollection 2025.
8
Rhoifolin Attenuates DSS-Induced Colitis in Mice by Modulating Gut Microbiota and Restoring Th17/Treg Balance.橙皮素通过调节肠道微生物群和恢复Th17/Treg平衡减轻DSS诱导的小鼠结肠炎。
J Inflamm Res. 2025 Aug 15;18:11109-11124. doi: 10.2147/JIR.S515002. eCollection 2025.
9
Impact of microplastics on the human gut microbiome: a systematic review of microbial composition, diversity, and metabolic disruptions.微塑料对人类肠道微生物群的影响:微生物组成、多样性和代谢紊乱的系统评价
BMC Gastroenterol. 2025 Aug 13;25(1):583. doi: 10.1186/s12876-025-04140-2.
10
Quantitative Alterations in Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.炎症性肠病中短链脂肪酸的定量变化:系统评价与荟萃分析
Biomolecules. 2025 Jul 15;15(7):1017. doi: 10.3390/biom15071017.
Int J Mol Sci. 2023 Jul 7;24(13):11217. doi: 10.3390/ijms241311217.
4
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.短链脂肪酸产生菌:人类肠道微生物群的关键组成部分。
Nutrients. 2023 May 6;15(9):2211. doi: 10.3390/nu15092211.
5
Regulation of short-chain fatty acids in the immune system.短链脂肪酸在免疫系统中的调节作用。
Front Immunol. 2023 May 5;14:1186892. doi: 10.3389/fimmu.2023.1186892. eCollection 2023.
6
Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line.短链脂肪酸——微生物组的产物及其在微生物组-宿主哺乳动物线上双向通讯中的参与。
Curr Obes Rep. 2023 Jun;12(2):108-126. doi: 10.1007/s13679-023-00503-6. Epub 2023 May 19.
7
The ketone body acetoacetate activates human neutrophils through FFAR2.酮体乙酰乙酸盐通过 FFAR2 激活人中性粒细胞。
J Leukoc Biol. 2023 Jun 1;113(6):577-587. doi: 10.1093/jleuko/qiad035.
8
Exploring the potential impact of probiotic use on drug metabolism and efficacy.探索益生菌使用对药物代谢和疗效的潜在影响。
Biomed Pharmacother. 2023 May;161:114468. doi: 10.1016/j.biopha.2023.114468. Epub 2023 Mar 1.
9
Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis.肠道微生物群及其代谢产物短链脂肪酸在新生儿坏死性小肠结肠炎中的治疗潜力
Life (Basel). 2023 Feb 16;13(2):561. doi: 10.3390/life13020561.
10
Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics.丁酸盐产生菌,“肠道哨兵”:它们在肠道中的意义及其与丁酸盐的关联及其他方面,以及作为微生物疗法的潜在用途。
Front Microbiol. 2023 Jan 12;13:1103836. doi: 10.3389/fmicb.2022.1103836. eCollection 2022.